These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32356245)

  • 41. History and Perspective on DIY Closed Looping.
    Lewis D
    J Diabetes Sci Technol; 2019 Jul; 13(4):790-793. PubMed ID: 30348013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.
    Phillip M; Nimri R; Bergenstal RM; Barnard-Kelly K; Danne T; Hovorka R; Kovatchev BP; Messer LH; Parkin CG; Ambler-Osborn L; Amiel SA; Bally L; Beck RW; Biester S; Biester T; Blanchette JE; Bosi E; Boughton CK; Breton MD; Brown SA; Buckingham BA; Cai A; Carlson AL; Castle JR; Choudhary P; Close KL; Cobelli C; Criego AB; Davis E; de Beaufort C; de Bock MI; DeSalvo DJ; DeVries JH; Dovc K; Doyle FJ; Ekhlaspour L; Shvalb NF; Forlenza GP; Gallen G; Garg SK; Gershenoff DC; Gonder-Frederick LA; Haidar A; Hartnell S; Heinemann L; Heller S; Hirsch IB; Hood KK; Isaacs D; Klonoff DC; Kordonouri O; Kowalski A; Laffel L; Lawton J; Lal RA; Leelarathna L; Maahs DM; Murphy HR; Nørgaard K; O'Neal D; Oser S; Oser T; Renard E; Riddell MC; Rodbard D; Russell SJ; Schatz DA; Shah VN; Sherr JL; Simonson GD; Wadwa RP; Ward C; Weinzimer SA; Wilmot EG; Battelino T
    Endocr Rev; 2023 Mar; 44(2):254-280. PubMed ID: 36066457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study.
    Schipp J; Skinner T; Holloway E; Scibilia R; Langstrup H; Speight J; Hendrieckx C
    Diabetes Technol Ther; 2021 Aug; 23(8):546-554. PubMed ID: 33720767
    [No Abstract]   [Full Text] [Related]  

  • 44. Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis.
    Karageorgiou V; Papaioannou TG; Bellos I; Alexandraki K; Tentolouris N; Stefanadis C; Chrousos GP; Tousoulis D
    Metabolism; 2019 Jan; 90():20-30. PubMed ID: 30321535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.
    Saunders A; Messer LH; Forlenza GP
    Expert Rev Med Devices; 2019 Oct; 16(10):845-853. PubMed ID: 31540557
    [No Abstract]   [Full Text] [Related]  

  • 47. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emotional and Physical Health Impact in Children and Adolescents and Their Caregivers Using Open-source Automated Insulin Delivery: Qualitative Analysis of Lived Experiences.
    Braune K; Krug N; Knoll C; Ballhausen H; Thieffry A; Chen Y; O'Donnell S; Raile K; Cleal B
    J Med Internet Res; 2022 Jul; 24(7):e37120. PubMed ID: 35834298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
    Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S
    Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Open source automated insulin delivery: addressing the challenge.
    Oliver N; Reddy M; Marriott C; Walker T; Heinemann L
    NPJ Digit Med; 2019; 2():124. PubMed ID: 31840095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Glycemia and Quality of Life Among Loop Users: Analysis of Real-world Data From a Single Center.
    Morrison AE; Chong K; Lai V; Farnsworth K; Senior PA; Lam A
    JMIR Diabetes; 2022 Oct; 7(4):e40326. PubMed ID: 36279156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol.
    de Bock M; McAuley SA; Abraham MB; Smith G; Nicholas J; Ambler GR; Cameron FJ; Fairchild JM; King BR; Geelhoed EA; Davis EA; O'Neal DN; Jones TW;
    BMJ Open; 2018 Aug; 8(8):e020275. PubMed ID: 30104309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.
    Woldaregay AZ; Årsand E; Walderhaug S; Albers D; Mamykina L; Botsis T; Hartvigsen G
    Artif Intell Med; 2019 Jul; 98():109-134. PubMed ID: 31383477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.
    Huhndt A; Chen Y; O'Donnell S; Cooper D; Ballhausen H; Gajewska KA; Froment T; Wäldchen M; Lewis DM; Raile K; Skinner TC; Braune K
    Front Clin Diabetes Healthc; 2022; 3():876511. PubMed ID: 36992765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action.
    Lee MY; Tanenbaum ML; Maahs DM; Prahalad P
    Case Rep Endocrinol; 2022; 2022():9911736. PubMed ID: 35273814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescribing unapproved medical devices? The case of DIY artificial pancreas systems.
    Roberts JTF; Moore V; Quigley M
    Med Law Int; 2021 Mar; 21(1):42-68. PubMed ID: 33958837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.
    Deshpande S; Pinsker JE; Zavitsanou S; Shi D; Tompot R; Church MM; Andre C; Doyle FJ; Dassau E
    Diabetes Technol Ther; 2019 Jan; 21(1):35-43. PubMed ID: 30547670
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.